Poland· PL-100520845
Lucetam
A piracetam product containing piracetamum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Piracetam is registered in 11 of 19 countries.
Countries holding a registration under ATC N06BX03 (piracetam), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Piracetam · ATC N06BX03
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of piracetam costs, country by country.
Normalised to the WHO defined daily dose (2.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Piracetam · price per daily dose (2.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.15
The record
At a glance
URPL (Poland)- Active substance
- Piracetamum
- Manufacturer
- Medezin Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N06BX03
- ATC class
- Piracetam
- Defined daily dose
- 2.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991579197
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Piracetam in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGERATAMUCB Pharma SA, Brusel
- BelgiumNootropil 1200 mgImpexeco
- FinlandNootropilAdvanz Pharma Limited
- SwedenNootrop 1200 mg Filmdragerad tablettOrifarm AB
- SwitzerlandNootropil 1200 mg, FilmtablettenAdvanz Pharma Specialty Medicine Switzerland GmbH
- NorwayNootropilUCB
- GermanyCebrotoninWalter Ritter Gmbh + Co. Kg
- FranceNOOTROPYL 20 %, solution buvableADVANZ PHARMA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Belgium · Nootropil, Piracetam Eg
- Bulgaria · Адицетам, Луцетам
- Cyprus · Nootropil
- Czechia · Geratam, Nootropil
- Germany · Cebrotonin, Nootrop
- Spain · Ciclofalina, Nootropil
- Finland · Nootropil
- France · Nootropyl, Piracetam Arrow
- United Kingdom (Northern Ireland) · Nootropil
- Greece · Meditam, Oxynium
- Hungary · Cognit, Lucetam
- Italy · Dizzitam, Ecumens
- Lithuania · Piracetam Kalceks, Piracetam-Egis
- Luxembourg · Nootropil, Piracetam Eg
- Latvia · Lucetam, Piracetam Kalceks
- Malta · Nootropil
- Netherlands · Piracetam Teva
- Norway · Nootropil
- Portugal · Acetar, Noostan
- Romania · Memotal, Nootropil
- Sweden · Nootropil
- Slovenia · Nootropil
- Slovakia · Lucetam, Pirabene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa550cea-c51b-4b03-ab41-1a59eaf7e828 GET /v1/drugs/fa550cea-c51b-4b03-ab41-1a59eaf7e828?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "1200 mg",
"packaging": "05909991579197 ¦ Rp ¦ 162695\n60 tabl.",
"substance": "Piracetamum 1200 mg",
"common_name": "Piracetamum",
"pl_product_id": "100520845",
"pozwolenie_nr": "218/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-06-26"
}See everything about piracetam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.